Soluble CD36 and Risk Markers of Insulin Resistance and Atherosclerosis Are Elevated in Polycystic Ovary Syndrome and Significantly Reduced During Pioglitazone Treatment
Open Access
- 1 February 2008
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 31 (2), 328-334
- https://doi.org/10.2337/dc07-1424
Abstract
OBJECTIVE—We investigated the relation between soluble CD36 (sCD36), risk markers of atherosclerosis and body composition, and glucose and lipid metabolism in polycystic ovary syndrome (PCOS).Keywords
This publication has 23 references indexed in Scilit:
- Rosiglitazone treatment alleviates inflammation and improves liver function in overweight women with polycystic ovary syndrome: a randomized placebo-controlled studyFertility and Sterility, 2007
- Identification of the Oxidized Low-Density Lipoprotein Scavenger Receptor CD36 in PlasmaCirculation, 2006
- Oxidised low-density lipoprotein concentration – early marker of an altered lipid metabolism in young women with PCOSActa Endocrinologica, 2006
- Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndromeFertility and Sterility, 2006
- Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 caucasian premenopausal women with hirsutism as the referral diagnosisFertility and Sterility, 2004
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertility and Sterility, 2004
- Effects of LDL cholesterol on vascular functionJournal of Human Hypertension, 2002
- CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolismJournal of Clinical Investigation, 2001
- Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in miceJournal of Clinical Investigation, 2000
- ABNORMAL ANDROGEN AND OESTROGEN METABOLISM IN MEN WITH STEROID SULPHATASE DEFICIENCY AND RECESSIVE X‐LINKED ICHTHYOSISClinical Endocrinology, 1985